documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
11 rows where docket_id = "FDA-2013-D-1445" sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: title, subtype, posted_date, posted_month, comment_start_date, open_for_comment, withdrawn, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2013-D-1445-0074 | FDA | None FDA-2013-D-1445 | Blood Glucose Monitoring Test Systems for Prescription Point-of-Care Use; Guidance for Industry and Food and Drug Administration Staff | Other | Guidance | 2020-10-05T04:00:00Z | 2020 | 10 | 2020-10-05T04:00:00Z | 2024-11-06T23:40:06Z | 1 | 0 | 09000064848d3169 | ||
| FDA-2013-D-1445-0073 | FDA | None FDA-2013-D-1445 | Blood Glucose Monitoring Test Systems for Prescription Point-of-Care Use Guidance for Industry and Food and Drug Administration Staff | Other | Guidance | 2020-09-29T04:00:00Z | 2020 | 9 | 2020-09-29T04:00:00Z | 2024-11-06T23:40:18Z | 1 | 0 | 090000648489b73e | ||
| FDA-2013-D-1445-0072 | FDA | None FDA-2013-D-1445 | Blood Glucose Monitoring Test Systems for Prescription Point-of-Care Use; Guidance for Industry and Food and Drug Administration Staff; Availability | Notice | Notice of Availability | 2020-09-29T04:00:00Z | 2020 | 9 | 2020-09-29T04:00:00Z | 2020-09-29T19:06:55Z | 2020-21463 | 0 | 0 | 090000648489886d | |
| FDA-2013-D-1445-0065 | FDA | None FDA-2013-D-1445 | Blood Glucose Monitoring Test Systems for Prescription Point-of-Care Use; Draft Guidance for Industry and Food and Drug Administration Staff; Availability | Notice | Notice of Availability | 2018-11-30T05:00:00Z | 2018 | 11 | 2018-11-30T05:00:00Z | 2019-03-01T04:59:59Z | 2024-11-12T22:50:38Z | 2018-26034 | 1 | 0 | 0900006483916275 |
| FDA-2013-D-1445-0066 | FDA | None FDA-2013-D-1445 | Blood Glucose Monitoring Test Systems for Prescription Point-of-Care Use Draft Guidance for Industry and Food and Drug Administration Staff | Other | Guidance | 2018-11-30T05:00:00Z | 2018 | 11 | 2018-11-30T05:00:00Z | 2024-11-12T22:49:53Z | 1 | 0 | 09000064839196ea | ||
| FDA-2013-D-1445-0062 | FDA | None FDA-2013-D-1445 | Blood Glucose Monitoring Test Systems for Prescription Point-of-Care Use; Guidance for Industry and Food and Drug Administration Staff; Availability | Notice | Notice of Availability | 2016-10-11T04:00:00Z | 2016 | 10 | 2016-10-11T04:00:00Z | 2016-10-11T15:17:52Z | 2016-24430 | 0 | 0 | 09000064822d1a6d | |
| FDA-2013-D-1445-0063 | FDA | None FDA-2013-D-1445 | Blood Glucose Monitoring Test Systems for Prescription Point-of-Care Use; Guidance for Industry and Food and Drug Administration Staff | Other | Guidance | 2016-10-11T04:00:00Z | 2016 | 10 | 2016-10-11T04:00:00Z | 2024-11-11T21:32:39Z | 1 | 0 | 09000064822dd986 | ||
| FDA-2013-D-1445-0013 | FDA | None FDA-2013-D-1445 | Blood Glucose Monitoring Test Systems for Prescription Point-of-Care Use; Draft Guidance for Industry and Food and Drug Administration Staff; Extension of Comment Period | Notice | Extension of Comment Period | 2014-04-09T04:00:00Z | 2014 | 4 | 2014-04-09T04:00:00Z | 2014-05-08T03:59:59Z | 2014-05-09T01:02:01Z | 2014-07898 | 0 | 0 | 09000064816ab265 |
| FDA-2013-D-1445-0012 | FDA | None FDA-2013-D-1445 | Blood Glucose Monitoring Test Systems for Prescription Point-of-Care Use; Draft Guidance for Industry and Food and Drug Administration Staff; Extension of Comment Period | Notice | 2014-04-09T00:00:00Z | 2014 | 4 | 2014-04-09T15:35:53Z | 0 | 1 | 09000064816ab3db | ||||
| FDA-2013-D-1445-0002 | FDA | None FDA-2013-D-1445 | Blood Glucose Monitoring Test Systems for Prescription Point-of-Care Use; Draft Guidance for Industry and Food and Drug Administration Staff | Other | Guidance | 2014-01-08T05:00:00Z | 2014 | 1 | 2014-01-08T05:00:00Z | 2024-11-07T23:01:39Z | 1 | 0 | 09000064814f47d7 | ||
| FDA-2013-D-1445-0001 | FDA | None FDA-2013-D-1445 | Blood Glucose Monitoring Test Systems for Prescription Point-of-Care Use; Draft Guidance for Industry and Food and Drug Administration Staff; Availability | Notice | Notice of Availability | 2014-01-07T05:00:00Z | 2014 | 1 | 2014-01-07T05:00:00Z | 2014-04-08T03:59:59Z | 2014-07-01T17:05:55Z | 2014-00023 | 0 | 0 | 09000064814f130a |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;